Back
Protagonist Therapeutics Vs. Jabil Industry Stock Comparison
Sell
48
PTGX
Protagonist Therapeutics
Last Price:
31.98
Seasonality Move:
-0.18%
Buy
52
JBL
Jabil
Last Price:
108.52
Seasonality Move:
7.32%
Sell
48
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $31.76. The Score for PTGX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Jabil (JBL)
is a Buy
Is Jabil a Buy, Sell or Hold?
- The current Jabil [JBL] share price is $112.24. The Score for JBL is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- JBL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $31.76
The current trend is moderately bullish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.
JBL Stock Price Chart
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.64 | Buy |
| Relative Strength Index (14 RSI): | 51.46 | Buy |
| Chaikin Money Flow: | 237349 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.7 - 33.76) | Buy |
| Bollinger Bands (100): | (26.44 - 31.46) | Buy |
JBL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.34 | Sell |
| Relative Strength Index (14 RSI): | 41.33 | Sell |
| Chaikin Money Flow: | 591366 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.9 - 120.94) | Sell |
| Bollinger Bands (100): | (116.7 - 140.02) | Sell |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.2 | Sell |
| 20-day SMA: | 31.94 | Sell |
| 50-day SMA: | 29.45 | Buy |
| 200-day SMA: | 24.03 | Buy |
| 8-day EMA: | 32.16 | Sell |
| 20-day EMA: | 31.88 | Sell |
| 50-day EMA: | 30.39 | Buy |
| 200-day EMA: | 25.87 | Buy |
JBL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 116.85 | Sell |
| 20-day SMA: | 117.12 | Sell |
| 50-day SMA: | 118.38 | Sell |
| 200-day SMA: | 126.37 | Sell |
| 8-day EMA: | 115.34 | Sell |
| 20-day EMA: | 116.91 | Sell |
| 50-day EMA: | 120.02 | Sell |
| 200-day EMA: | 120.84 | Sell |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $4.32 per share, and a decrease next year of $2.45 per share.
Jabil Earnings Growth & JBL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, an increase next quarter of $0.34 per share, a decrease this year of $0.08 per share, and an increase next year of $0.81 per share.
Protagonist Therapeutics Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Jabil Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||